Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate
Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate
Biote 2024年第一季度GAAP每股收益（0.06）未達到0.03美元的預期，銷售額爲4,6804萬美元，超過4571.1萬美元的預期
Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 percent. This is a 84.62 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $46.804 million which beat the analyst consensus estimate of $45.711 million by 2.39 percent. This is a 4.37 percent increase over sales of $44.843 million the same period last year.
Biote（納斯達克股票代碼：BTMD）公佈的季度虧損爲每股0.06美元，比分析師普遍預期的0.03美元低300％。與去年同期每股虧損（0.39）美元相比，增長了84.62％。該公司公佈的季度銷售額爲4,6804萬美元，比分析師普遍預期的4571.1萬美元高出2.39％。這比去年同期的4,484.3萬美元的銷售額增長了4.37％。